A European map fo access to migraine treatments
Over 41 million Europeans live with migraine, but access to diagnosis and effective treatment is not equal everywhere.
Now you can see the differences in access, availability and affordability of migraine treatments, country by country.
This interactive map reveals the real story behind migraine care in 12 European countries (Germany, Serbia, France, Greece, Spain, Italy, Portugal, Switzerland, UK, Finland, Czech Republic and Netherlands), based on patient associations and EMHA studies.
This interactive map gathers information from 12 European countries, to show:
- Where the most innovative treatments are available
- How much patients must pay for their medication
- What barriers they face in accessing the care they need
Explore the map here
If you wish to share the tool with members of your organisations or with anyone else you think might be interested.  Campaign materials are available to share. If you share this, please tag us (@emhalliance) and help amplify the conversation on migraine access across Europe.
